3692.HK
Price:
$23.45
Market Cap:
$128.61B
Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People's Republic of China. The company provides products for therapeutic areas, including central nervous system diseases, oncology, anti-infectives, and metabolic diseases. Its principal products include Mailingda, a drug for the treatment of chronic myelogenous leukemia; and Ameile, Hansoh Xinfu, Pulaile, Zefei, Xinwei, Xinmei, Xintai, Tanneng, Oulanning, Ameining, Zetan, Hengjie, Hengsen, Fulaimei, Fulaidi, and Ruibote drugs. The company serves pharmaceutical product distributors. It has a strategic collaboration with Sc...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2019-06-14
Stock Exchange
HKSE
Ticker
3692.HK
According to Hansoh Pharmaceutical Group Company Limited’s latest financial reports and current stock price. The company's current PE Ratio is 29.68. This represents a change of 147.56% compared to the average of 11.99 of the last 4 quarters.
The mean historical PE Ratio of Hansoh Pharmaceutical Group Company Limited over the last ten years is 45.76. The current 29.68 PE Ratio has changed 6.39% with respect to the historical average. Over the past ten years (40 quarters), 3692.HK's PE Ratio was at its highest in in the January 2016 quarter at 63.72. The PE Ratio was at its lowest in in the June 2024 quarter at 8.05.
Average
45.76
Median
49.57
Minimum
22.01
Maximum
72.36
Discovering the peaks and valleys of Hansoh Pharmaceutical Group Company Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 45.98%
Maximum Annual PE Ratio = 72.36
Minimum Annual Increase = -53.33%
Minimum Annual PE Ratio = 22.01
Year | PE Ratio | Change |
---|---|---|
2024 | 22.01 | -19.44% |
2023 | 27.33 | -8.92% |
2022 | 30.00 | -11.16% |
2021 | 33.77 | -53.33% |
2020 | 72.36 | 45.98% |
2019 | 49.57 | -3.40% |
2018 | 51.31 | -11.60% |
2017 | 58.04 | -13.97% |
The current PE Ratio of Hansoh Pharmaceutical Group Company Limited (3692.HK) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
26.45
5-year avg
37.09
10-year avg
45.76
Hansoh Pharmaceutical Group Company Limited’s PE Ratio is greater than Innovent Biologics, Inc. (-828.47), greater than WuXi AppTec Co., Ltd. (15.62), greater than Pharmaron Beijing Co., Ltd. (21.66), greater than BeiGene, Ltd. (-113.30), greater than Shanghai Junshi Biosciences Co., Ltd. (-23.03),
Company | PE Ratio | Market cap |
---|---|---|
-828.47 | $84.13B | |
15.62 | $184.58B | |
21.66 | $40.98B | |
-113.30 | $206.62B | |
-23.03 | $27.99B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hansoh Pharmaceutical Group Company Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Hansoh Pharmaceutical Group Company Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Hansoh Pharmaceutical Group Company Limited's PE Ratio?
How is the PE Ratio calculated for Hansoh Pharmaceutical Group Company Limited (3692.HK)?
What is the highest PE Ratio for Hansoh Pharmaceutical Group Company Limited (3692.HK)?
What is the 3-year average PE Ratio for Hansoh Pharmaceutical Group Company Limited (3692.HK)?
What is the 5-year average PE Ratio for Hansoh Pharmaceutical Group Company Limited (3692.HK)?
How does the current PE Ratio for Hansoh Pharmaceutical Group Company Limited (3692.HK) compare to its historical average?